PE20030359A1 - Indan-1-oles sustituidos en c2 y sus derivados, procedimiento para su preparacion - Google Patents
Indan-1-oles sustituidos en c2 y sus derivados, procedimiento para su preparacionInfo
- Publication number
- PE20030359A1 PE20030359A1 PE2002000802A PE2002000802A PE20030359A1 PE 20030359 A1 PE20030359 A1 PE 20030359A1 PE 2002000802 A PE2002000802 A PE 2002000802A PE 2002000802 A PE2002000802 A PE 2002000802A PE 20030359 A1 PE20030359 A1 PE 20030359A1
- Authority
- PE
- Peru
- Prior art keywords
- indan
- alkyl
- derivatives
- substituted
- procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- BEJJBCSFWDCXFP-UHFFFAOYSA-N 5-chloro-2-propan-2-ylsulfonyl-2,3-dihydro-1h-inden-1-ol Chemical compound ClC1=CC=C2C(O)C(S(=O)(=O)C(C)C)CC2=C1 BEJJBCSFWDCXFP-UHFFFAOYSA-N 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/17—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/20—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE INDAN-1-LES SUSTITUIDAS EN C2 Y SUS DERIVADOS DE FORMULA I DONDE: a) R1-R4 SON H; X ES S, SO, SO2; Y ES (CH2)p DONDE p PUEDE SER 0-3; R5 ES CF3, ALQUILO C2-C18, CICLOALQUILO C3-C4, CICLOALQUILO C6-C8, DONDE LOS GRUPOS ALQUILO PUEDEN ESTAR REEMPLAZADOS CON F; b) R1 Y R4 SON H, F, Cl, Br, I, CH, N3, NO2, OH, ENTRE OTROS, R2 Y R3 SON H, F, Cl, Br, I, CH, N3, OALQUILO C1-C8, OCICLOALQUILO C3-C8, O-CO-ALQUILO C1-C8, ENTRE OTROS, R2 Y R3 JUNTOS FORMAN EL GRUPO -O-CH2-O-, ENTRE OTROS, R4 ES DIFERENTE DE H, X ES S, SO, SO2; Y ES (CH2)p SIENDO p 0-3; R5 ES ALQUILO C1-C18, CICLAOLQUILO C3-C4 Y C6-C8 , ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y COMPUESTOS INTERMEDIOS. SON COMPUESTOS PREFERIDOS 5-CLORO-2-METILSULFANIL-INDAN-1-OL, 5-CLORO-2-(PROPAN-2-SULFONIL)-INDAN-1-OL, 5-CLORO-2-ETANOSULFONIL-INDAN-1-OL, ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON UTILES PARA EL TRATAMIENTO DE OBESIDAD
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10142667A DE10142667B4 (de) | 2001-08-31 | 2001-08-31 | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030359A1 true PE20030359A1 (es) | 2003-05-20 |
Family
ID=7697237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000802A PE20030359A1 (es) | 2001-08-31 | 2002-08-21 | Indan-1-oles sustituidos en c2 y sus derivados, procedimiento para su preparacion |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US6657086B2 (es) |
| EP (1) | EP1425266B1 (es) |
| JP (1) | JP4263999B2 (es) |
| AR (1) | AR036676A1 (es) |
| AT (1) | ATE429418T1 (es) |
| AU (1) | AU2002333449B2 (es) |
| CA (1) | CA2458527A1 (es) |
| DE (2) | DE10142667B4 (es) |
| IL (1) | IL160606A0 (es) |
| MX (1) | MXPA04001856A (es) |
| PE (1) | PE20030359A1 (es) |
| WO (1) | WO2003020696A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| DE10142666A1 (de) * | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| JP5253155B2 (ja) * | 2005-06-02 | 2013-07-31 | ジェンリン ディスカバリー | 肥満治療に有用なｍａｏ−ｂ阻害剤 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3043824A (en) * | 1959-09-28 | 1962-07-10 | Exxon Research Engineering Co | Hydroperoxide and sulfoxide compounds |
| US3016348A (en) * | 1959-11-02 | 1962-01-09 | Universal Oil Prod Co | Manufacture and use of sulfided hydrocarbon purification catalyst |
| US3642785A (en) * | 1969-08-11 | 1972-02-15 | Merck & Co Inc | Indenyl-3-aliphatic amines |
| FR2201882B1 (es) * | 1972-07-20 | 1975-10-31 | Logeais Labor Jacques | |
| GB1465794A (en) * | 1974-05-17 | 1977-03-02 | Wyeth John & Brother Ltd | Thiourea derivatives |
| DE2640358A1 (de) * | 1976-09-08 | 1978-03-16 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
| EP0009554B1 (de) | 1978-07-27 | 1983-04-27 | Schering Aktiengesellschaft | Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| RU2073673C1 (ru) | 1987-10-19 | 1997-02-20 | Пфайзер Инк. | Рацемические и оптические активные производные тетралина и 7-гидрокситетралина |
| IL124756A0 (en) | 1995-12-06 | 1999-01-26 | Venantius Limited | Indane dimer compounds and their pharmaceutical use |
| WO1997026265A1 (en) | 1996-01-17 | 1997-07-24 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| DE19705402B4 (de) | 1996-07-17 | 2007-04-26 | Robert Bosch Gmbh | Gassensor |
| PT944648E (pt) | 1996-08-30 | 2007-06-26 | Novo Nordisk As | Derivados do glp-1. |
| IL127296A (en) | 1996-12-31 | 2003-01-12 | Reddy Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| HUP0003999A3 (en) | 1997-07-16 | 2003-03-28 | Novo Nordisk As | Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them |
| FR2769312B1 (fr) * | 1997-10-03 | 1999-12-03 | Adir | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2782515B1 (fr) * | 1998-08-21 | 2000-09-22 | Adir | NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
| EP1078632A1 (en) | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
-
2001
- 2001-08-31 DE DE10142667A patent/DE10142667B4/de not_active Expired - Fee Related
-
2002
- 2002-08-17 EP EP02797586A patent/EP1425266B1/de not_active Expired - Lifetime
- 2002-08-17 JP JP2003524967A patent/JP4263999B2/ja not_active Expired - Fee Related
- 2002-08-17 DE DE50213487T patent/DE50213487D1/de not_active Expired - Lifetime
- 2002-08-17 AT AT02797586T patent/ATE429418T1/de not_active IP Right Cessation
- 2002-08-17 AU AU2002333449A patent/AU2002333449B2/en not_active Ceased
- 2002-08-17 IL IL16060602A patent/IL160606A0/xx unknown
- 2002-08-17 MX MXPA04001856A patent/MXPA04001856A/es active IP Right Grant
- 2002-08-17 WO PCT/EP2002/009206 patent/WO2003020696A1/de active Application Filing
- 2002-08-17 CA CA002458527A patent/CA2458527A1/en not_active Abandoned
- 2002-08-21 PE PE2002000802A patent/PE20030359A1/es not_active Application Discontinuation
- 2002-08-29 AR ARP020103252A patent/AR036676A1/es not_active Application Discontinuation
- 2002-08-30 US US10/231,394 patent/US6657086B2/en not_active Expired - Lifetime
-
2003
- 2003-09-22 US US10/665,021 patent/US20040068016A1/en not_active Abandoned
- 2003-09-22 US US10/664,855 patent/US7045649B2/en not_active Expired - Lifetime
-
2004
- 2004-11-04 US US10/981,045 patent/US7015208B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003020696A1 (de) | 2003-03-13 |
| US20040068016A1 (en) | 2004-04-08 |
| JP4263999B2 (ja) | 2009-05-13 |
| DE10142667A1 (de) | 2003-03-27 |
| US6657086B2 (en) | 2003-12-02 |
| US20050113595A1 (en) | 2005-05-26 |
| US20050101798A1 (en) | 2005-05-12 |
| IL160606A0 (en) | 2004-07-25 |
| US20030114681A1 (en) | 2003-06-19 |
| MXPA04001856A (es) | 2004-06-15 |
| AU2002333449B2 (en) | 2007-09-06 |
| EP1425266B1 (de) | 2009-04-22 |
| JP2005525297A (ja) | 2005-08-25 |
| US7015208B2 (en) | 2006-03-21 |
| US7045649B2 (en) | 2006-05-16 |
| ATE429418T1 (de) | 2009-05-15 |
| DE50213487D1 (de) | 2009-06-04 |
| DE10142667B4 (de) | 2004-06-09 |
| EP1425266A1 (de) | 2004-06-09 |
| AR036676A1 (es) | 2004-09-29 |
| CA2458527A1 (en) | 2003-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20050142A1 (es) | 2-hidroxi-3-diaminoalcanos de benzamida | |
| AR006720A1 (es) | Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
| CY1110651T1 (el) | Παραγωγα της ν-'(1,5-διφαινυλ-1η- πυραζολ-3-υλ)μεθυλ σουλφοναμιδης με μια συγγενεια για τους υποδοχεις cb1 | |
| AR037901A1 (es) | Beta-amino-alfa-cianoacrilatos | |
| PE20020858A1 (es) | Indanil aminas aciladas | |
| ATE369855T1 (de) | Modulatoren von peroxisome proliferator- aktivierten rezeptoren | |
| DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| PE20071254A1 (es) | Derivados de sulfonamidas como agentes moduladores de los receptores de orexina y su preparacion | |
| PE20061490A1 (es) | Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1 | |
| AR064459A1 (es) | Derivados de sulfonamida | |
| AR053340A1 (es) | Derivados de trifluormetilbenzamida y sus usos terapeuticos | |
| DE3467348D1 (de) | N-(2-nitrophenyl)-4-aminopyrimidine derivatives as microbicides | |
| PE20001063A1 (es) | Nuevos agentes antibacterianos de isoxazolinona | |
| SV2009002925A (es) | Derivados de oxadiazol | |
| PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
| PE20030761A1 (es) | Derivados del 7-amino-benzotiazol | |
| NO20076402L (no) | Imaging 18F or 11C-labelled alkylthiophenyl guanidines | |
| AR043487A1 (es) | Heterociclos fusionados de pirimidina y usos de los mismos | |
| CO5640122A2 (es) | Nuevos compuestos de azetidina | |
| ES2121183T3 (es) | Ligandos selectivos de los receptores 5ht1d-5ht1b derivados de indol-piperacina utiles como medicamentos. | |
| CO5690578A2 (es) | Derivados de acido 4-(3-(2-feniloxazol-4-ilmetoxi)ciclohexiloxi)-butanoico y compuestos relacionados como moduladores de ppar para tratar la diabetes tipo 2 y la aterosclerosis | |
| PE20030363A1 (es) | Utilizacion de sistemas de indan-1-ol varias veces sustituidos, para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad | |
| RS51186B (sr) | Derivati oksadiazolona kao ppar delta agonisti | |
| PE20030359A1 (es) | Indan-1-oles sustituidos en c2 y sus derivados, procedimiento para su preparacion | |
| NO984597L (no) | Amino- og hydroksysubstituerte trifenyl-s-triaziner som stabilisatorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |